(CTN News) – In a news release issued on Monday, the FDA Food and Drug Administration approved AstraZeneca and Sanofi’s vaccine that protects infants and toddlers against respiratory syncytial virus, the leading cause of hospitalization among babies in the United States. Despite the fact that it has not been approved for use in infants with […]
Related Articles
This post first appeared on Data Analytics Can Be A Powerful Tool Against Cybercrime’s Meteoric Rise In South East Asia, please read the originial post: here
